Celon Pharma

Update in progress

CLN.WA (Warsaw)

Company RatingNeutral
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic

Celon Pharma S.A. is an integrated pharmaceutical company focused on research, manufacturing, and marketing of specialized generic medicines. It develops and supplies drugs for cancer, neurological disorders, diabetes, and other metabolic conditions. Founded in 2002, the company is based in Lomianki, Poland, and operates as a subsidiary of Glatton Sp. z o.o.

Company score

Sentiment: 0.41; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.29; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.00; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.08; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.24; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive